SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?


To: Arthur Radley who wrote (589)3/1/2000 12:50:00 AM
From: RCMac  Read Replies (1) | Respond to of 626
 
On the issue "Will Zomaril (iloperidone) be approved?", see the interesting comments by an apparently well-informed contributor calling himself "pharmexec" on the Yahoo TTP board:

messages.yahoo.com

The punch line: "In my estimate the chance for success [approval of Zomaril/iloperiodne] is approximately 90%.

See also his post #2711: messages.yahoo.com